|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Gandhi TK, Bartel SB, Shulman LN, Verrier D, Burdick E, Cleary A, Rothschild JM, Leape LL, Bates DW. 2005. Medication safety in the ambulatory chemotherapy setting. Cancer 104(11):2477–2483. Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Edmondson AC, Bates DW. 2000. Incidence and preventability of adverse drug events in nursing homes. American Journal of Medicine 109(2):87–94. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW. 2003. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. Journal of the American Medical Association 289(9):1107–1116. Gurwitz JH, Field TS, Judge J, Rochon P, Harrold LR, Cadoret C, Lee M, White K, LaPrino J, Mainard JF, DeFlorio M, Gavendo L, Auger J, Bates DW. 2005. The incidence of adverse drug events in two large academic long-term care facilities. American Journal of Medicine 118(3):251–258. IFoM (International Forum on Medicine). 2003. Presentation of the Forum and Current Agenda Areas. The Hague, The Netherlands: International Pharmaceutical Federation. IMS (Intercontinental Marketing Services). 2003. IMS Reports 11.5% Dollar Growth in 2002 U.S. Prescription Sales. [Online]. Available: http://imshealth.com/ims/portal/front/articleC/0,2777,6372_3665_41276589,00.html [accessed October 27, 2005]. IMS. 2004. IMS Reports 11.5 Percent Dollar Growth in ‘03 U.S. Prescription Sales. [Online]. Available: http://www.imshealth.com/ims/portal/front/articleC/0,2777,6599_40183881_44771558,00.html [accessed October 27, 2005]. IMS. 2005. IMS Reports 8.3 Percent Dollar Growth in 2004 U.S. Prescription Sales. [Online]. Available: http://ir.imshealth.com/phoenix.zhtml?c=67124&p=irol-newsArticle&ID=674505&highlight= [accessed October 27, 2005]. IOM (Institute of Medicine). 2000. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press. IOM. 2001. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press. IOM. 2004. Patient Safety: Achieving a New Standard for Care. Washington, DC: The National Academies Press. JCAHO (Joint Commision on Accreditation of Healthcare Organizations). 2006. Facts About the 2006 National Patient Safety Goals.[Online]. Available: http://www.jcipatientsafety.org/show.asp?durki=9726 [accessed August 16, 2006]. Johnson JA, Bootman JL. 1997. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. American Journal of Health-System Pharmacy 54: 554–558. Kaiser Family Foundation. 1999. Kaiser/Harvard Health News Index: November-December 1999. [Online]. Available: http://www.kff.org/kaiserpolls/upload/13350_1.pdf [accessed May 25, 2005]. Kaiser Family Foundation. 2004. Prescription Drug Trends—October 2004. [Online]. Available: http://www.kff.org/rxdrugs/3057-03.cfm [accessed October 26, 2005]. Kaiser Family Foundation. 2005. Medicare Fact Sheet: March 2005. [Online]. Available: http://www.kff.org/medicare/loader.cfm?url=/commonspot/security/getfile.cfm&PageID=33325 [accessed May 25, 2005]. Leape LL, Berwick DM. 2005. Five years after To Err Is Human: What have we learned? Journal of the American Medical Association 293(19):2384–2390. Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, Hebert L, Newhouse JP, Weiler PC, Hiatt H. 1991. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. New England Journal of Medicine 324(6):377–384.
|
|
|||||||||||||||
